Real-world evidence evaluating continuation of CDK4/6 inhibitors beyond first progression in hormone receptor-positive (HR+) metastatic breast cancer.

标题
Real-world evidence evaluating continuation of CDK4/6 inhibitors beyond first progression in hormone receptor-positive (HR+) metastatic breast cancer.
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume 37, Issue 15_suppl, Pages e12538-e12538
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2019-05-27
DOI
10.1200/jco.2019.37.15_suppl.e12538

向作者/读者发起求助以获取更多资源

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now